Navigation Links
Gene variations explain drug dose required to control seizures

elative safety for a particular treatment.

Similarly, appropriate doses of carbamazepine take time to determine because of the drug's variable affects on patient metabolism and its potential neurologic side effects.

The team identified genes considered to be obvious candidates underlying patients' drug response, based on their known roles in the metabolism or transport of one or both anti-epileptic drugs. In 425 epileptic patients taking carbamazepine and 281 taking phenytoin, the researchers then searched for an association between clinical use of the drugs and variation in the candidate genes.

One variant of a gene known as CYP2C9, which encodes a liver enzyme involved in drug metabolism, showed a significant association with the maximum dose of phenytoin taken by patients with epilepsy.

Moreover, a variant of a second gene, called SCN1A, with activity in the brain, was found significantly more often in patients on the highest doses of both carbamazepine and phenytoin. SCN1A has been implicated in many inherited forms of epilepsy and is the drug target for phenytoin.

Given its relationship to both anti-epileptic drugs tested, the SCN1A variant may be of particular importance for understanding patient response to drug treatment, said the researchers, noting that many other anti-epilepsy drugs act on related brain proteins.

"The range of doses taken by patients at epilepsy clinics is great," Goldstein said. "For someone at the higher end, it can take months to get their seizures under control. This study uncovers factors that might determine, in advance, which patients will need the higher dose."

Before any such pharmacogenetic approaches can be put into practice, they must be explicitly evaluated for clinical utility in improving patient outcomes, Goldstein said.

The new findings provide a direction for a dosing scheme that could be tested in the clinic to assess whether pharmacogenetic diagnostics can
'"/>

Source:Duke University Medical Center


Page: 1 2 3 4

Related biology news :

1. Researchers map of genetic variations implicated in disease
2. A new kind of mutation could explain numerous phenotypic variations in various species
3. Gene variations contribute to aggression and anger in women
4. Jumping gene helps explain immune systems abilities
5. Gene sequencing explains bioremediation bug
6. Variation in womens X chromosomes may explain differences among individuals, between sexes
7. Iron exporter revealed that may explain common human disorder
8. New book explains antibiotic resistance for a broad audience
9. Cats indifference towards sugar explained
10. Monkeypox mystery: New research may explain why 2003 outbreak in the US wasnt deadly
11. Scientist uses form to explain function of key building blocks of life
Post Your Comments:
(Date:12/16/2009)... source of financial and technical assistance to developing countries ... appear to be connected to space technology, but large ... intrinsically linked. , Global climate change is also an ... in the poorest countries and communities, which will suffer ... led to a growing demand for information about the ...
(Date:12/16/2009)... determined that short-term, seasonal exposure to pesticides in ... size of wild salmon populations. In addition to ... suggest that exposure to commonly used pesticides may ... populations. , "Major efforts are currently underway ... to recover depressed populations," says David Baldwin of ...
(Date:12/16/2009)... of Maryland School of Medicine researcher will lead the ... prominent scientists in the field of stem cell research. ... Medicine, was chosen by the National Heart, Lung and ... consortium of national experts, which will be called the ... be funded by a $30 million grant over seven ...
Breaking Biology News(10 mins):ESA and World Bank move toward closer collaboration 2ESA and World Bank move toward closer collaboration 3ESA and World Bank move toward closer collaboration 4Even at sublethal levels, pesticides may slow the recovery of wild salmon populations 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 2University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium 3NightHawk Radiology Launches Redesigned Quality Assurance Program 6601 1NightHawk Radiology Launches Redesigned Quality Assurance Program 6601 2Reportlinker Adds Surgical Incision Closures Global Trends 6596 1Reportlinker Adds Surgical Incision Closures Global Trends 6596 2Reportlinker Adds Surgical Incision Closures Global Trends 6596 3Reportlinker Adds Surgical Incision Closures Global Trends 6596 4Reportlinker Adds Surgical Incision Closures Global Trends 6596 5Reportlinker Adds Surgical Incision Closures Global Trends 6596 6Reportlinker Adds Surgical Incision Closures Global Trends 6596 7eHealthSource com Launches Online Shopping Site Dedicated to Over the Counter Medications Approved for FSA HSA Claims 6590 1eHealthSource com Launches Online Shopping Site Dedicated to Over the Counter Medications Approved for FSA HSA Claims 6590 2
... partnership between Syracuse University and the Serum Institute of ... for children living in some of the most impoverished ... $250,000 to a team of SU researchers led by ... of Arts and Sciences, to develop new oral vaccines ...
... known as HACNS1, that may have contributed to the evolution ... in the ankle or foot that allow humans to walk ... Science on Sept. 5, 2008. , This study is ... gene enhancers, which are switches near genes in the human ...
... Fla. The development of powerful supercomputers capable ... of an eye mark a technological milestone capable ... and business worldwide. Researchers at the University of ... collaborating with NCAR (National Center for Atmospheric Research), ...
Other Biology News:Syracuse University partners with Serum Institute of India to develop vaccines for children 2Syracuse University partners with Serum Institute of India to develop vaccines for children 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4Gene enhancer in evolution of human opposable thumb 2Gene enhancer in evolution of human opposable thumb 3Petascale climate modeling heats up at University of Miami 2Petascale climate modeling heats up at University of Miami 3
(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...
(Date:12/15/2009)... Dec. 15 Thomson ... ® has become the first drug pipeline database ... outcome information. This highly anticipated new content is ... month. ,, Thomson Pharma ... registries, publications, press releases, conferences, and other sources ...
(Date:12/14/2009)... -- Vermillion, Inc. (Pink Sheets: VRML), a ... Wallen, Ph.D. Chief Scientific Officer, Senior Vice ... will be joining its board of directors ... ,, "Bill brings more than 20 years ... biotechnology," said Gail Page, Vermillion Executive Chairperson. ...
(Date:12/14/2009)... Scientific Corporation (NYSE: BSX ) today announced ... aggregate principal amount of its senior notes under the ... of $850 million of 4.50 percent notes due January ... 2020 and $300 million of 7.375 percent notes due ... net proceeds for general corporate purposes, including prepaying its ...
Breaking Biology Technology:Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3
... Researchers at the National Institute of Standards and Technology ... levels of stress or strain in regions of a ... recent results* not only will impact the design of ... rest a long-standing disagreement in results between two different ...
... MNKD ), focused on discovering, developing and commercializing,treatments ... at,the Piper Jaffray 20th Annual Health Care Conference on Tuesday, ... Palace Hotel in New York City. , ... the live web cast of the,presentation in the Investor Relations ...
... Celator Pharmaceuticals today announced that Scott Jackson, chief executive officer, ... Health Care Conference in New York and the 2008 Mid-Atlantic ... corporate overview and an update on the company,s clinical development ... , ...
Other Biology Technology:NIST 'stress tests' probe nanoscale strains in materials 2Celator(R) Pharmaceuticals to Present at Piper Jaffray Health Care Conference and Mid-Atlantic Capital Conference 2
... V, is used to coat the inner wall ... the source of the DNA that enters target ... gun. The station includes a tubing support cylinder, ... Nalgene nitrogen regulator hose, two 0.1875 inch barb-to-male ...
... Pack provides optimized blocking and wash ... Clarifier: Ready-to-use wash solutions have been ... Coated Slides for Microarrays (Product Code ... Buffer: 1L • Microarray Post Hybridization ...
Mouse monoclonal antibody raised against a partial recombinant NR4A2. NCBI Entrez Gene ID = NR4A2...
... dedicated imaging system for detection of very ... pixel size. Equipped with an extreme sensitive ... animals or plants in tumor research, infectious ... Western blots. NightOWL is the only imager ...
Biology Products: